Endotoxemia and human liver transplantation [PDF]
Ninety liver transplantations were performed in 81 patients. Plasma endotoxin was measured preoperatively, at the end of the anhepatic phase, and on postoperative days 1, 3, and 7.
Miyata, T +5 more
core
Experience in hepatic resection for metastatic colorectal cancer: Analysis of clinical and pathologic risk factors [PDF]
Background. The selection of patients for resective therapy of hepatic colorectal metastases remains controversial. A number of clinical and pathologic prognostic risk factors have been variably reported to influence survival. Methods.
Doerr, RJ +9 more
core
Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant Use. [PDF]
Background and aimsAll-oral interferon-free antivirals are highly effective in treating recurrent hepatitis C (HCV) infection in liver transplant (LT) recipients.
Bau, Sherona +12 more
core +2 more sources
Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients [PDF]
Background: Whereas it is well established that various soluble biomarkers can predict level of liver fibrosis, their ability to predict liver-related clinical outcomes is less clearly established, in particular among HIV/viral hepatitis co-infected ...
Karlsson, Anders +9 more
core
Objective To investigate the predictive value of the model for end-stage liver disease(MELD) score combined with procalcitonin(PCT) for acute kidney injury in patients with hepatitis B virus-associated acute-on-chronic liver failure(HBV-ACLF).
Chunxu Wang, Lin Wang, Hongyan Wang
doaj +1 more source
Kidney function and mortality post-liver transplant in the Model for End-Stage Liver Disease era
Aastha Sethi1, Michelle M Estrella1, Richard Ugarte2, Mohamed G Atta1 1Johns Hopkins University School of Medicine, Department of Medicine, Baltimore, MD, USA; 2University of Maryland Medical Center, Department of Medicine, Baltimore, MD, USA Abstract ...
Sethi A, Estrella MM, Ugarte R, Atta MG
doaj
Model for end-stage liver disease (MELD) exception guidelines [PDF]
Russell, Wiesner +3 more
openaire +2 more sources
The Effect of Model for End-Stage Liver Disease 3.0 on Disparities between Patients with and without Hepatocellular Carcinoma in Korea. [PDF]
Kim K, Kim DG, Lee JG, Joo DJ, Lee HW.
europepmc +1 more source
Predicted Impact of the Model for End-Stage Liver Disease 3.0 in a Region Suffering Severe Organ Shortage. [PDF]
Kim DG +6 more
europepmc +1 more source
Model for end-stage liver disease-sodium in acute-on-chronic liver failure [PDF]
Paul Manka, Ali Canbay, Lars P. Bechmann
openaire +3 more sources

